Public-registry site landscape for NCT05583188, a NSCLC study sponsored by Galvanize Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05583188 (registry record) |
| Sponsor | Galvanize Therapeutics, Inc. |
| Condition(s) | NSCLC |
| Phase | PHASE4 |
| Listed sites | 3 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05583188 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →